NYSE:CVS - CVS Health Stock Price, News & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Wednesday, July 10th. Stockholders of record on Thursday, July 25th will be given a dividend of $0.50 per share on Friday, August 2nd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.32%. The ex-dividend date is Wednesday, July 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) released its earnings results on Wednesday, August, 7th. The pharmacy operator reported $1.89 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.70 by $0.19. The pharmacy operator earned $63.43 billion during the quarter, compared to analysts' expectations of $62.66 billion. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. CVS Health's revenue was up 35.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.69 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for CVS Health.

CVS Health issued an update on its FY19 earnings guidance on Wednesday, August, 7th. The company provided earnings per share guidance of $6.89-7.00 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.84.

25 equities research analysts have issued 12-month price objectives for CVS Health's stock. Their predictions range from $61.00 to $100.00. On average, they expect CVS Health's stock price to reach $75.1429 in the next year. This suggests a possible upside of 24.7% from the stock's current price. View Analyst Price Targets for CVS Health.

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 1 sell rating, 7 hold ratings, 16 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

News stories about CVS stock have trended negative on Sunday, according to InfoTrie Sentiment. The research group rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CVS Health earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave news articles about the pharmacy operator a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for CVS Health.

Some companies that are related to CVS Health include Express Scripts (ESRX), Walgreens Boots Alliance (WBA), Covetrus (CVET), Diplomat Pharmacy (DPLO), Petmed Express (PETS), Rite Aid (RAD), 111 (YI), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), NVIDIA (NVDA), Johnson & Johnson (JNJ), Cisco Systems (CSCO), Alibaba Group (BABA), Bank of America (BAC), Intel (INTC), Micron Technology (MU) and Verizon Communications (VZ).

CVS Health's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (7.87%), Price T Rowe Associates Inc. MD (1.43%), Northern Trust Corp (1.41%), Barrow Hanley Mewhinney & Strauss LLC (1.31%), Morgan Stanley (1.06%) and Bank of New York Mellon Corp (1.05%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Parnassus Investments CA, CIBC Private Wealth Group LLC, Prudential Financial Inc., UBS Asset Management Americas Inc., Bank of New York Mellon Corp, Pictet Asset Management Ltd. and Pictet Asset Management Ltd.. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, James David Clark, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was acquired by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Morgan Stanley, Prudential PLC, Vanguard Group Inc., Parametric Portfolio Associates LLC, Poplar Forest Capital LLC, Invesco Ltd. and LSV Asset Management. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $60.28.

CVS Health has a market capitalization of $78.39 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]